Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Transmeta
posted on
Apr 16, 2005 06:38AM
``Transmeta has been up for sale for at least five months. But with a market capitalization of around $200 million, it has no takers at present. Advanced Micro Devices, the number-two PC microprocessor maker behind Intel, could use Transmeta’s technology but hasn’t been willing to pay the steep price. And while Intel could have used Transmeta’s technology five years ago, it doesn’t need it now.``
